Bennett J P, Enna S J, Bylund D B, Gillin J C, Wyatt R J, Snyder S H
Arch Gen Psychiatry. 1979 Aug;36(9):927-34. doi: 10.1001/archpsyc.1979.01780090013001.
Frontal cerebral cortex brain samples from schizophrenics and controls have been assayed for binding associated with muscarinic cholinergic, serotonin (5HT), gamma-aminobutyric acid (GABA), and beta-adrenergic receptors as well as for the activity of the GABA-synthesizing enzyme glutamic acid decarboxylase (GAD). Binding levels of tritium-LSD, presumably associated with postsynaptic 5HT receptors, were reduced 40% to 50% in samples from schizophrenics in three independent studies, whereas no other consistent alteration was observed in levels of binding associated with other receptors or in the activity of GAD. This change in receptor binding levels does not seem to be attributable to postmortem changes, to influence of drugs received by the patients, or to demographic features of the patient populations.
已对精神分裂症患者和对照组的额叶大脑皮质脑样本进行检测,以分析与毒蕈碱型胆碱能、5-羟色胺(5HT)、γ-氨基丁酸(GABA)和β-肾上腺素能受体相关的结合情况,以及GABA合成酶谷氨酸脱羧酶(GAD)的活性。在三项独立研究中,来自精神分裂症患者样本中,推测与突触后5HT受体相关的氚-LSD结合水平降低了40%至50%,而与其他受体相关的结合水平或GAD活性未观察到其他一致的变化。受体结合水平的这种变化似乎并非归因于死后变化、患者所接受药物的影响或患者群体的人口统计学特征。